Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology ROA 2010-2025 | POAI

Current and historical return on assets (ROA) values for Predictive Oncology (POAI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Predictive Oncology ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $-0.01B $0.01B -137.93%
2024-12-31 $-0.01B $0.01B -141.18%
2024-09-30 $-0.01B $0.01B -120.93%
2024-06-30 $-0.01B $0.01B -96.30%
2024-03-31 $-0.01B $0.01B -87.50%
2023-12-31 $-0.01B $0.01B -66.67%
2023-09-30 $-0.02B $0.02B -80.00%
2023-06-30 $-0.02B $0.02B -72.38%
2023-03-31 $-0.03B $0.03B -83.33%
2022-12-31 $-0.03B $0.03B -74.07%
2022-09-30 $-0.03B $0.03B -65.36%
2022-06-30 $-0.03B $0.04B -60.82%
2022-03-31 $-0.02B $0.04B -39.58%
2021-12-31 $-0.02B $0.04B -41.67%
2021-09-30 $-0.02B $0.05B -57.14%
2021-06-30 $-0.03B $0.06B -74.07%
2021-03-31 $-0.03B $0.04B -99.05%
2020-12-31 $-0.03B $0.01B -120.00%
2020-09-30 $-0.03B $0.03B -121.21%
2020-06-30 $-0.03B $0.03B -101.89%
2020-03-31 $-0.02B $0.03B -79.28%
2019-12-31 $-0.02B $0.02B -87.91%
2019-09-30 $-0.01B $0.03B -49.32%
2019-06-30 $-0.01B $0.03B -69.57%
2019-03-31 $-0.01B $0.01B -244.44%
2018-12-31 $-0.01B $0.00B -210.53%
2018-09-30 $-0.01B $0.01B -168.42%
2018-06-30 $-0.01B $0.00B -141.18%
2018-03-31 $-0.01B $0.01B -155.56%
2017-12-31 $-0.01B $0.00B -141.18%
2017-09-30 $-0.01B $0.00B -150.00%
2017-06-30 $-0.01B $0.01B -160.00%
2017-03-31 $-0.01B $0.01B -184.62%
2016-12-31 $-0.01B $0.00B -233.33%
2016-09-30 $-0.01B $0.00B -213.33%
2016-06-30 $-0.01B $0.00B -152.38%
2016-03-31 $-0.01B $0.00B -126.32%
2015-12-31 $0.00B $0.01B -100.00%
2015-09-30 $0.00B $0.01B -145.45%
2015-06-30 $0.00B $0.00B -400.00%
2015-03-31 $-0.01B $0.00B -500.00%
2014-12-31 $-0.01B $0.00B -700.00%
2014-09-30 $-0.01B $0.00B -700.00%
2014-06-30 $-0.01B $0.00B -1000.00%
2014-03-31 $-0.01B $0.00B -1200.00%
2013-12-31 $-0.01B $0.00B -1200.00%
2013-09-30 $-0.01B $0.00B -1800.00%
2013-06-30 $-0.01B $0.00B -3200.00%
2013-03-31 $-0.01B $0.00B -3600.00%
2012-12-31 $-0.01B $0.00B 0.00%
2012-09-30 $-0.01B $0.00B 0.00%
2012-06-30 $-0.01B $0.00B 0.00%
2012-03-31 $-0.01B $0.00B 0.00%
2011-12-31 $0.00B $0.00B 0.00%
2011-09-30 $0.00B $0.00B 0.00%
2011-06-30 $0.00B $0.00B 0.00%
2011-03-31 $0.00B $0.00B 0.00%
2010-12-31 $0.00B $0.00B 0.00%
2010-09-30 $0.00B $0.00B 0.00%
2010-06-30 $0.00B $0.00B 0.00%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.007B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.313B 58.92
Tempus AI (TEM) United States $11.516B 0.00
Doximity (DOCS) United States $11.474B 53.12
Hims & Hers Health (HIMS) United States $11.060B 114.91
IRhythm Technologies (IRTC) United States $4.939B 0.00
Inspire Medical Systems (INSP) United States $3.905B 61.02
Hinge Health (HNGE) United States $3.629B 0.00
Privia Health (PRVA) United States $2.682B 183.33
Enovis (ENOV) United States $1.815B 10.12
Phreesia (PHR) United States $1.695B 0.00
Schrodinger (SDGR) United States $1.512B 0.00
10x Genomics (TXG) United States $1.444B 0.00
Clover Health Investments (CLOV) United States $1.405B 0.00
Azenta (AZTA) United States $1.400B 65.08
Omnicell (OMCL) United States $1.376B 24.28
Evolent Health (EVH) United States $1.310B 111.60
Claritev (CTEV) United States $0.716B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Butterfly Network (BFLY) United States $0.485B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.452B 0.00
TruBridge (TBRG) United States $0.349B 773.33
Outset Medical (OM) United States $0.338B 0.00
Health Catalyst (HCAT) United States $0.265B 0.00
Nyxoah SA (NYXH) Belgium $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.167B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
American Well (AMWL) United States $0.124B 0.00
MDxHealth SA (MDXH) Belgium $0.109B 0.00
Pulmonx (LUNG) United States $0.105B 0.00
CareCloud (CCLD) United States $0.102B 3.89
Insight Molecular Diagnostics (IMDX) United States $0.092B 0.00
111 (YI) China $0.060B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.051B 0.00
HeartBeam (BEAT) United States $0.046B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00